Pregabalin Capsule 75 mg (Pregabalin)

Adult dose

This medication is a Pregabalin taken orally, divided into two doses per day regardless of food. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain - Initial dose: 150 mg per day - May increase to 300 mg per day 3 to 7 days later - If needed, may increase to a maximum of 600 mg per day at 7-day intervals. 2) Central Neuropathic Pain - Initial dose: 150 mg per day.

Child dose

There is insufficient safety and efficacy data for children under 12 years old and adolescents aged 12 to 17 years, so use is not recommended.

This medication may increase the risk of suicidal thoughts and behaviors, so careful observation for any abnormal changes in mood or behavior during treatment is necessary. Patients with hypersensitivity to this medication or genetic conditions related to lactose should not take it. Diabetes patients may require blood sugar control due to weight gain, and if symptoms of angioedema occur, they should stop taking the medication immediately. Elderly patients should be particularly cautious at the beginning of treatment due to the risk of accidents from dizziness or drowsiness. If you experience blurred vision or changes in eyesight, consult a doctor, as symptoms may improve upon stopping the medication. Caution is advised when switching to this medication as monotherapy, as withdrawal symptoms such as insomnia, headache, and anxiety may occur after discontinuation. Patients with a history of drug abuse should use this medication carefully due to the risk of abuse. Patients with impaired kidney function may require dose adjustments, and those with heart failure should also exercise caution. Care must be taken when taking this medication with opioid analgesics due to the risk of central nervous system depression, and precautions should be taken for patients who may experience respiratory depression. In early pregnancy, there is a risk of fetal malformations, so this medication should not be administered to pregnant women, except in special cases, and women of childbearing age should use effective contraception. Breastfeeding women should consider stopping breastfeeding or discontinuing the medication as it can be transmitted through breast milk. Caution is necessary at the beginning of treatment with this medication due to the risk of accidents from dizziness and drowsiness while driving or operating machinery. Severe skin reactions may occur, so if any unusual skin symptoms appear, the medication should be stopped immediately and a doctor should be consulted. Overdose may result in symptoms such as drowsiness, confusion, and depression, and blood dialysis treatment may be required if necessary. This medication should be kept out of the reach of children and transferring it to another container should be avoided.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion of consciousness, vision abnormalities, paralysis, urination issues.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication must be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is at room temperature between 1 to 30 degrees Celsius.

Appearance

A hard capsule with upper reddish-brown and lower white color containing white or slightly yellow powder.

Package unit

30 capsules/bottle, 60 capsules/bottle, 100 capsules/bottle